Lymphoma Steering Committee

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Lymphoma Steering Committee (LYSC) was established in 2009.

Mission Statement

The LYSC follows an efficient, cost-effective, science-driven, and transparent process to identify and promote the "Best Science" in clinical research on lymphoma and related diseases by addressing the design and prioritization of phase 3 trials and large phase 2 studies.

Roster of Lymphoma Steering Committee members


2015 Lymphoma Steering Committee Strategic Priorities

LYSC Activities

Clinical Trials Planning Meetings (CTPMs)

  • Lymphoma – November 2014
  • B-Cell Lymphoma (DLBCL) Working Group – October 2010
  • Executive Summary

CCCT Contact: Lawrence Baizer, Ph.D.